Olympus and Bracco ink marketing plan

By AuntMinnie.com staff writers

May 19, 2022 -- Olympus and Bracco Diagnostics have entered a strategic co-marketing agreement to promote the role of endoscopic ultrasound (EUS) with contrast in the characterization of focal liver lesions.

The technology, called contrast-enhanced harmonic endoscopic ultrasound (CH-EUS), is primed to open pathways for more innovative and timely diagnosis and treatment of liver disease, the companies said.

CH-EUS is the use of a contrast agent containing microbubbles and an endoscopic ultrasound system designed to allow the detection of microbubbles within the vasculature, with the intent to provide a more detailed view of potential pathology.

Under terms of the agreement, Olympus will co-market Bracco Diagnostic's Lumason ultrasound-enhancing agent.


Copyright © 2022 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: